The nation of Zimbabwe has turned down a substantial American healthcare agreement worth $367m (£272m) over five years over Washington's request for confidential information.
This move became public after a internal memorandum from December was disclosed, revealing that Head of State Emmerson Mnangagwa deemed the deal was "lopsided".
An official representative later explained that the US was seeking biological samples for research and profit but was not willing to guarantee the resulting advantages from future medical innovations.
"We are forced to start the challenging and unfortunate task of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had donated more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has appealed for more negotiations to reach a deal agreeable to all parties so the country's vital HIV programme can proceed.
Wider Context
This rejection comes after a similar situation in Kenya, where a high court halted a related health funding agreement after concerns were raised about the safety of citizens' medical information.
Since resuming the presidency last year, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
The agency had managed assistance for the American government, but Trump argued its expenditure was "wasteful" and his government was seeking government-to-government agreements to enhance openness and accountability.
As per reports, Sixteen African countries have so far agreed to these new agreements, constituting over $18.3bn in new funding.
Specifics of the Rejected Agreement
This assistance for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration would have delivered significant advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently on antiretroviral therapy via American-funded initiatives," Tremont said.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"Our nation was requested to provide its genetic material and health information for a long time, with no equivalent guarantee of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could result from that shared data," Mangwana explained.
"Effectively, our country would provide the basic resources for medical research with no certainty that the final treatments would be available to our people if a future health crisis emerge."
Sovereignty and International Frameworks
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were upending systems previously set up through the international health agency.
Mangwana cited its Pandemic Benefit-Sharing system designed to deal with future pandemics.
"This framework is designed to guarantee that when a country contributes its samples, the benefits – such as medicines and cures – are distributed fairly, not commercialised solely by those with the capability to develop them."
These objections regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We are open to continued dialogue with our US partners on how future collaboration could be structured in a way that honours the independence and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but urged that talks should continue given that a large portion of the nation's Aids initiatives depended on external financing.
"If technical issues exist, including those involving information security or implementation frameworks, these can frequently be addressed via detailed discussion and negotiated safeguards," the group said.
The situation emphasises the ongoing debate between accepting much-needed foreign assistance and safeguarding a country's data in an ever more interconnected world.